News & Press: Latest News

MDMA Statement on Senate Small Business Committee Hearing to Examine the Patent System

Thursday, February 25, 2016  
Share |

MDMA Statement on Senate Small Business Committee Hearing to Examine the Patent System

Washington, D.C. – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding the Senate Committee on Small Business and Entrepreneurship hearing entitled, “An Examination of Changes to the U.S. Patent System and Impacts on America’s Small Businesses:”

“MDMA thanks Chairman Vitter and the committee Members for examining the unintended consequences that some proposed changes to the patent system would have on small businesses.  MDMA continues to support balanced efforts to curb abusive patent practices, but not in a manner that would be overly broad and would harm medical technology innovation and stifle the development of cures for patients who need them the most.

MDMA remains committed to working with Congress on targeted efforts to improve the patent system, but we must not do so at the expense of innovators and inventors who are revolutionizing patient care and saving lives.”

###